AR and prostate carcinoma: Using PAINTOR together with 20 functional categories previously implicated in prostate cancer, a significant enrichment of prostate cancer-associated variants was found in FOX1A-binding sites assayed in the LNCaP cell line (derived from androgen-sensitive human prostate adenocarcinoma cells) and at binding sites for the androgen receptor.